PARP and Androgen-Signaling Inhibition plus ADT in Metastatic Prostate Cancer - Neeraj Agarwal; Nobuaki Matsubara; Arun A. Azad; Fred Saad; Joaquin Mateo; Shusuan Jiang; Dingwei Ye; Eric Voog; Neal D. Shore; Timuçin Çil; Christof Vulsteke; Hsiao-Jen Chung; et al. (New England Journal of Medicine, 2026)